IBD LIVE Case Series-Case 4: Worms in IBD: Friend or Foe.
نویسندگان
چکیده
LEARNING OBJECTIVES After completing this journal-based activity, physicians should be better able to: 1. Define the “hygiene hypothesis” of autoimmune diseases. 2. Understand the reasoning behind Trichuris suis ova (TSO) therapy for inflammatory bowel disease. 3. Know the key findings of trials using TSO in patients with Crohn’s disease and ulcerative colitis. 4. Be aware of the potential risks regarding helminth therapy. 5. Know the current opinion regarding TSO treatment in inflammatory bowel disease. 6. Be aware of the scope of complementary and alternative medicine (CAM) use in the United States, particularly among individuals with inflammatory bowel disease.
منابع مشابه
The Microbiome and Diet: Friend or Foe in the Future Treatment of Inflammatory Bowel Disease?
It is well established that uncontrolled activation of effector immune cells in response to the gut microbiota triggers chronic inflammatory bowel disease (IBD) symptoms in genetically susceptible hosts. The exact cause(s) for IBD remains unknown. Previous studies have examined, in detail, how the gut microbiome, genetic susceptibility, and environmental stress may activate the immune responses...
متن کاملIBD LIVE Case Series--Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial.
LEARNING OBJECTIVES After completing this IBD LIVE-CME activity, physicians should be better able to: 1. Identify monogenic causes of early onset IBD. 2. Know when genetic testing might benefit the management of select IBD patients. 3. Be aware of potential clinical, endoscopic and histologic findings in early onset IBD. 4. Understand the pathophysiology and potential clinical course of IBD in ...
متن کاملIBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn’s Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment? Peter N. Le, MD,* Julia B. Greer, MD, MPH, Ioannis Oikonomou, MD, Wolfgang H. Schraut, MD, Corey A. Siegel, MD,jj Raymond K. Cross, MD, MS, Stefan D. Holubar, MD, MS,** Andrew Tinsley, MD, Walter A. Koltun, MD, David G. Binion, MD, and Migu...
متن کاملCD4 count remission hypothesis in patients with inflammatory bowel disease and human immunodeficiency virus infection: a systematic review of the literature
BACKGROUND Patients with inflammatory bowel disease (IBD) and human immunodeficiency virus (HIV) infection have shown controversial data concerning the remission hypothesis of IBD due to CD4 count depletion caused by HIV. The aim of our systematic review was to investigate the hypothesis whether low CD4 count due to HIV is related to IBD remission. METHODS We systematically searched PubMed fo...
متن کاملIsolation, Characterization and Standardization of New Infectious Bursal Disease Virus for Development of a Live Vaccine
Background and Aims: Infectious bursal disease (IBD) is an acute contagious viral disease of birds worldwide. The causative virus induces a persistent immune suppression following destroy B lymphocytes precursors in bursal lymphoid follicles. Vaccination is the main strategy for prevention of the disease in commercial poultry industry. Materials and Methods: To produce a live vaccine against th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Inflammatory bowel diseases
دوره 22 6 شماره
صفحات -
تاریخ انتشار 2016